CoChat

Transgenic mice for in vivo epigenome editing with CRISPR-based systems

Open access
Gemberling, Matthew P., Siklenka, Keith, Rodriguez, Erica, Tonn-Eisinger, Katherine R., Barrera, Alejandro, Liu, Fang, Kantor, Ariel, Li, Liqing, Cigliola, Valentina, Hazlett, Mariah F., Williams, Courtney A., Bartelt, Luke C., Madigan, Victoria J., Bodle, Josephine C., Daniels, Heather, Rouse, Douglas C., Hilton, Isaac B., Asokan, Aravind, Ciofani, Maria, Poss, Kenneth D., Reddy, Timothy E., West, Anne E., Gersbach, Charles A. · 2021 · Nature Methods
Cited by 140

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Abstract

CRISPR-Cas9 technologies have dramatically increased the ease of targeting DNA sequences in the genomes of living systems. The fusion of chromatin-modifying domains to nuclease-deactivated Cas9 (dCas9) has enabled targeted epigenome editing in both cultured cells and animal models. However, delivering large dCas9 fusion proteins to target cells and tissues is an obstacle to the widespread adoption of these tools for in vivo studies. Here, we describe the generation and characterization of two conditional transgenic mouse lines for epigenome editing, Rosa26:LSL-dCas9-p300 for gene activation and Rosa26:LSL-dCas9-KRAB for gene repression. By targeting the guide RNAs to transcriptional start sites or distal enhancer elements, we demonstrate regulation of target genes and corresponding changes to epigenetic states and downstream phenotypes in the brain and liver in vivo, and in T cells and fibroblasts ex vivo. These mouse lines are convenient and valuable tools for facile, temporally controlled, and tissue-restricted epigenome editing and manipulation of gene expression in vivo. Two conditional transgenic mouse lines based on CRISPRa and CRISPRi enable epigenome editing in vivo.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41592-021-01207-2

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Cited by

See all 140

Metadata

Authors
Gemberling, M. P., Siklenka, K., Rodriguez, E., Tonn-Eisinger, K. R., Barrera, A., Liu, F., Kantor, A., Li, L., Cigliola, V., Hazlett, M. F., Williams, C. A., Bartelt, L. C., Madigan, V. J., Bodle, J. C., Daniels, H., Rouse, D. C., Hilton, I. B., Asokan, A., Ciofani, M., Poss, K. D., Reddy, T. E., West, A. E., & Gersbach, C. A.
Venue
Nature Methods
Published
2021-08
Volume
18
Issue
8
Pages
965-974
ISSN
  • 1548-7091 (ISSN-L)
  • 1548-7105
OpenAlex
W3190049048
Cited by
140
References
29
FWCI
5.30
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Transgenic mice for in vivo epigenome editing with CRISPR-based systems. https://app.cochat.ai/papers/10.1038/s41592-021-01207-2
The paper
Gemberling, M. P., Siklenka, K., Rodriguez, E., Tonn-Eisinger, K. R., Barrera, A., Liu, F., Kantor, A., Li, L., Cigliola, V., Hazlett, M. F., Williams, C. A., Bartelt, L. C., Madigan, V. J., Bodle, J. C., Daniels, H., Rouse, D. C., Hilton, I. B., Asokan, A., Ciofani, M., . . . Gersbach, C. A. (2021). Transgenic mice for in vivo epigenome editing with CRISPR-based systems. Nature Methods. https://doi.org/10.1038/s41592-021-01207-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.